About Rulia ltd
Glowura+ Peptide Pen Kit | GHK-Cu, BPC-157 & TB-500 Research Peptides
Explore Glowura+ peptide pen kit featuring GHK-Cu, BPC-157, and TB-500. Designed for advanced laboratory research and precision peptide studies.
Glowura+ is a multi-peptide research formulation combining GHK-Cu, BPC-157, and TB-500, three widely studied compounds in peptide research. Developed for laboratory environments, this advanced peptide pen kit supports investigation into cellular pathways, tissue models, and regenerative research frameworks.
The precision delivery format allows for consistent handling, making Glowura+ suitable for controlled experimental protocols where repeatability and accuracy are essential. Each peptide component is commonly explored in research related to cellular signaling, structural protein interactions, and recovery pathways.
- peptide pen kit
- GHK-Cu research peptide
- BPC-157 laboratory research
- TB-500 peptide study
- multi-peptide formulation
- Combined GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg)
- Designed for laboratory and research environments
- Precision-format delivery system
- Suitable for multi-pathway peptide research
Tirzepatide 40mg Research Peptide | GLP-1 & GIP Dual Agonist
High-quality Tirzepatide 40mg research peptide. Dual GLP-1 and GIP receptor agonist for advanced metabolic and receptor pathway studies.
Tirzepatide is a dual agonist peptide studied for its interaction with GLP-1 and GIP receptors, making it a key compound in modern metabolic and receptor-based research. Supplied in a precision-controlled format, this 40mg peptide is designed to support consistent laboratory investigation.
Within research settings, Tirzepatide is frequently explored for its role in metabolic signaling pathways, receptor activity, and energy regulation models. Its dual mechanism makes it a valuable subject in studies examining complex biological interactions.
- Tirzepatide research peptide
- GLP-1 GIP agonist
- metabolic peptide research
- appetite pathway research
- receptor signaling peptide
- 40mg high-purity peptide content
- Dual GLP-1 / GIP receptor interaction
- Suitable for metabolic pathway research
- Precision formulation for laboratory use
Retatrutide 40mg Research Peptide | GLP-1, GIP & Glucagon Agonist
Retatrutide 40mg triple agonist peptide for advanced research. Investigate GLP-1, GIP, and glucagon receptor pathways in laboratory settings.
Retatrutide is a next-generation triple agonist peptide studied for its interaction with GLP-1, GIP, and glucagon receptors. This multi-pathway profile makes it highly relevant in advanced research exploring complex metabolic and receptor signaling systems.
Designed for laboratory applications, Retatrutide 40mg supports structured experimental use where multi-receptor interaction is a focus. Its unique mechanism allows researchers to investigate broader biological responses across interconnected pathways.
- Retatrutide research peptide
- triple agonist peptide
- GLP-1 GIP glucagon research
- metabolic pathway research peptide
- advanced peptide study
Key Features:
- 40mg triple agonist peptide
- GLP-1, GIP, and glucagon receptor interaction
- Suitable for advanced research models
- Designed for precision and consistency